Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-051268
Filing Date
2021-10-04
Accepted
2021-10-04 08:22:03
Documents
2
Period of Report
2021-10-04

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF PRIVATE ISSUER ea148338-6k_tiziana.htm 6-K 13375
2 REGULATORY NEWS SERVICE ANNOUNCEMENT, DATED OCTOBER 4, 2021 ea148338ex99-1_tiziana.htm EX-99.1 11287
  Complete submission text file 0001213900-21-051268.txt   25695
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences plc (Filer) CIK: 0001723069 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38723 | Film No.: 211301096
SIC: 2834 Pharmaceutical Preparations